0.06Open0.06Pre Close0 Volume647 Open Interest85.00Strike Price0.00Turnover4959.03%IV11.81%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.06Extrinsic Value100Contract SizeAmericanOptions Type-0.0251Delta0.0095Gamma1605.17Leverage Ratio-274.8999Theta0.0000Rho-40.28Eff Leverage0.0001Vega
Merck & Co Stock Discussion
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
Gapping up
$Merck & Co (MRK.US)$ shares modestly rose by 0.4% after securing a lucrative deal with LaNova Medicines, aimed at developing and marketing a new cancer treatment, potentially worth $3.3 billion.
$Disney (DIS.US)$ experienced a 9% increase in stock prices after surpassing expected fourth-quarter income and revenue, driven by strong performance in its streaming services, which significantly boosted i...
Why is Portfolio Diversification Important?
1. Risk Reduction:
Diversification...
On Monday, former President Donald Trump surpassed Vice President Kamala Harris in polling support for the first time since August.
This follows betting markets indicating a higher probability of a Trump victory in the upcoming 🗳 election.
Man has a large capacity for eff...
No comment yet